Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RF24 |
Human umbilical vascular endothelial cells | Human | vasculature | unknown | adherent | plasmid | Metafectene PRO | application note | ![]() |
||||
Rat VSMC |
Rat vascular smooth muscle cells | Rat | vasculature | unknown | plasmid | DOTAP | publication | W. Li et al., Am J Physiol Heart Circ Physiol, Jan 2005; 288: H408 - H415 | |||||
Rat VSMC |
Rat (Wistar) vascular smooth muscle cells from thoracic aorta | Rat | vasculature | unknown | siRNA | RNA-Interference | Metafectene | publication | A. Giordano et al., Am J Physiol Heart Circ Physiol, Jun 2006; 290: H2459 - H2465 | Link | |||
pPSMC |
Porcine primary smooth muscle cells | Swine | vasculature | primary cell | adherent | plasmid | Metafectene | publication | J. Pelisek et al., J Mol Med (Berl), Nov 2002; 80(11): 724-36 | ||||
pPSMC |
Porcine primary smooth muscle cells | Swine | vasculature | primary cell | adherent | plasmid | Metafectene | application note | ![]() |
||||
pPPAEC |
Porcine primary pulmonary artery endothelial cells | Swine | vasculature | primary cell | adherent | plasmid | Metafectene | publication | B. Wojciak-Stothard et al., Am J Physiol Lung Cell Mol Physiol, Apr 2005; 288: L749 - L760 | Link | |||
pBAEC |
Bovine primary aortic endothelial cells | Cow | vasculature | primary cell | adherent | plasmid | Metafectene PRO | publication | A. Nayebosadri et al., Am J Physiol Cell Physiol, Aug 2013; 305: C309 - C322 | Link | |||
pBAEC |
Bovine primary aortic endothelial cells | Cow | vasculature | primary cell | adherent | siRNA | RNA-Interference | Metafectene | publication | Y. Riahi et al., Diabetes, Apr 2010; 59: 808 - 818 | Link | ||
pBAEC |
Bovine primary aortic endothelial cells | Cow | vasculature | primary cell | adherent | plasmid | Metafectene | publication | K. Renner at al., J. Cell. Physiol., 2012, 227: 398–2411, DOI: 10.1002/jcp.22975 | ||||
PASMC |
Pulmonary artery smooth muscle cells | unknown | vasculature | unknown | plasmid | Metafectene | publication | W. Zhang et al., Sheng Li Xue Bao, Feb 2006; 58(1): 71-6 | |||||
PAEC |
Porcine primary aortic endothelial cells | Swine | vasculature | primary cell | adherent | plasmid | Metafectene | publication | B. Wojciak-Stothard et al., Am J Physiol Lung Cell Mol Physiol, Jun 2006; 290: L1173 - L1182 | Link | |||
PAEC |
Porcine primary aortic endothelial cells | Swine | vasculature | primary cell | adherent | plasmid | Metafectene PRO | publication | B. Wojciak-Stothard et al., J.Cell Sci, March 2007;120: 929-942 | Link | |||
MOVAS-1 |
Mouse aorta smooth muscle cells | ATCC CRL-2797 | Mouse | vasculature | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | B. Park et al., Bioscience, Biotechnology, and Biochemistry, 2015, 79(4): 539-552; DOI: 10.1080/09168451.2014.991681 | Link | |
MOVAS-1 |
Mouse aorta smooth muscle cells | ATCC CRL-2797 | Mouse | vasculature | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | K. Lee et al., Arch. Pharm. Res., 2016, 39:83-93; DOI 10.1007/s12272-015-0687-3 | ||
MOVAS-1 |
Mouse aorta smooth muscle cells | ATCC CRL-2797 | Mouse | vasculature | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | B. Park et al., Bioscience, Biotechnology, and Biochemistry, 2015, 79(4): 539-552; DOI: 10.1080/09168451.2014.991681 | Link | |
hVSMC |
Human vascular (aortic) smooth muscle cells | Human | vasculature | unknown | adherent | siRNA | RNA-Interference | Metafectene | publication | A. Giordano et al., Cardiovasc Res, Aug 2008; 79: 519 - 526 | Link | ||
hVSMC |
Human primary vascular smooth muscle cells | Human | vasculature | primary cell | adherent | plasmid | stable transfection | Metafectene | publication | G. Weisinger et al., Exp. Cell Res., 2013, 319: 1586-1593, doi.org/10.1016/j.yexcr.2013.04.001 | |||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | S. Thakker et al., Oncotarget, 2018, 9 (1): 1210-1228 | Link | |
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | J. Park et al., Biochem. and Biophys. Res. Commun., 2018, 495: 2050-2057, doi.org/10.1016/j.bbrc.2017.08.023 | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | siRNA | RNA-Interference | Metafectene | publication | A. Giordano et al., Am J Physiol Heart Circ Physiol, Jan 2012; 302: H135 - H142 | Link | |
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | plasmid | Metafectene PRO | publication | S.-W. Lee et al., Molecular Therapy, 2013, 21 (9): 1767–1777, doi:10.1038/mt.2013.146 | Link | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | oligonucleotide | DOTAP | publication | A. Avinó et al., Protocols in Nucleic Acid Chemistry, 2020, 77: e78, doi: 10.1002/cpnc.78 | |||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | plasmid | Metafectene PRO | publication | S. Bellou et al., Am J Physiol Cell Physiol, Dec 2009; 297: C1477 - C1489 | |||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | oligonucleotide | Metafectene | application note | ![]() |
|||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S.-W. Lee et al., Molecular Therapy, 2013, 21 (9): 1767–1777, doi:10.1038/mt.2013.146 | Link |